STOCK TITAN

Tiziana Life Sciences (TLSA) insider adds 42,357 shares via Panetta Partners

(Neutral)
(Neutral)
Form Type
4/A

Rhea-AI Filing Summary

Tiziana Life Sciences Ltd insider Gabriele M. Cerrone, a director and ten percent owner, indirectly purchased 42,357 shares of common stock on July 21, 2026 at $0.99 per share, through Panetta Partners Limited. Following this open-market purchase, indirect holdings total 44,814,587 shares. The Form 4/A corrects the earliest transaction date and transaction code for this purchase; no other reported transactions are changed.

Positive

  • None.

Negative

  • None.
Insider CERRONE GABRIELE M
Role Director, 10% Owner
Bought 42,357 shs ($42K)
Type Security Shares Price Value
Purchase COMMON STOCK 42,357 $0.99 $42K
Holdings After Transaction: COMMON STOCK — 44,814,587 shares (Indirect, Via Panetta Partners Limited)
Shares purchased 42,357 shares Common stock purchased on 2026-07-21 in open market transaction
Purchase price $0.99 per share Price paid for TLSA common stock on 2026-07-21
Indirect holdings after transaction 44,814,587 shares Total common shares indirectly owned via Panetta Partners Limited after purchase
Net buy shares 42,357 shares Net share change across all reported non-derivative transactions in this filing
Transaction code P Purchase in open market or private transaction; corrected in this Form 4/A
Transaction date 2026-07-21 Corrected earliest transaction date for this reported open market purchase
Purchase in open market or private transaction financial
"transaction_code_description: Purchase in open market or private transaction"
indirect financial
"ownership_type set to indirect with nature of ownership Via Panetta Partners Limited"
ten percent owner regulatory
"reporting person is marked as is_ten_percent_owner: 1"
Form 4/A regulatory
"This Form 4/A amends the Form 4 filed on June 23, 2026"
Form 4/A is an amended filing that corrects or updates an earlier Form 4, the mandatory report that insiders (like company executives, directors, or large shareholders) must file when their ownership stakes change. Think of it as an edited receipt showing who bought or sold stock and when; investors use it to track insider confidence, detect potential conflicts, and spot trading patterns that might signal future company prospects.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What insider transaction did TLSA report in this Form 4/A?

Tiziana Life Sciences Ltd reported that insider Gabriele M. Cerrone indirectly purchased 42,357 common shares on July 21, 2026 at $0.99 per share. The trade is coded as a purchase in an open market or private transaction and increases his indirect ownership.

How many TLSA shares does Gabriele M. Cerrone own after this transaction?

After the reported purchase, Gabriele M. Cerrone indirectly owns 44,814,587 shares of Tiziana Life Sciences common stock. These shares are held via Panetta Partners Limited, reflecting his status as a director and ten percent owner of the company.

At what price were the TLSA shares acquired in the amended Form 4/A?

The shares were acquired at $0.99 per share. The transaction involved buying 42,357 common shares of Tiziana Life Sciences Ltd in an open market purchase, as indicated by transaction code P and the description of a purchase in open market or private transaction.

What did the Tiziana Life Sciences (TLSA) Form 4/A amendment change?

The amendment states it was filed solely to correct the date of the earliest transaction and the transaction code associated with this open market purchase. It also clarifies that no other reported transactions are affected by this amendment.

Is the TLSA insider transaction reported as indirect ownership?

Yes. The Form 4/A lists the ownership as indirect, with the nature of ownership described as "Via Panetta Partners Limited". This means the 42,357 shares purchased and the 44,814,587 shares held after the trade are attributed to an entity associated with the insider.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
CERRONE GABRIELE M

(Last)(First)(Middle)
14-15 CONDUIT ST

(Street)
LONDONW1S2XJ

(City)(State)(Zip)

UNITED KINGDOM

(Country)
2. Issuer Name and Ticker or Trading Symbol
Tiziana Life Sciences Ltd [ TLSA ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirectorX10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
07/21/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)
07/23/2026
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
COMMON STOCK07/21/2026P42,357A$0.9944,814,587IVia Panetta Partners Limited
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
Remarks:
This Form 4/A amends the Form 4 filed on June 23, 2026 solely to correct the date of the earliest transaction and the transaction code associated with this open market purchase. No other reported transactions are affected by this amendment.
/s/ Gabriele M. Cerrone08/07/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)